Back

Prasugrel or clopidogrel in patients with acute coronary syndromes at high thrombotic risk: results from the PROMETHEUS study

27 August 2021 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Highlights from the Young in coronary artery disease Pharmacotherapy ESC Premium Access ESC Congress 2021 - The Digital Experience

About the speaker

Photo
Doctor Mauro Chiarito

Clinical Institute Humanitas IRCCS, Rozzano (Italy)

3 More presentations in this session

Presentation thumbnail
Cannabis use is associated with prevalent coronary artery disease
Doctor N. Patel (Winston-Salem, US)
Abstract Slides Video
Presentation thumbnail
Dispatch of lay-responders is associated with bystander cardiopulmonary resuscitation, bystander defibrillation and 30-day survival following an out-of-hospital cardiac arrest.
Doctor M. Jonsson (Stockholm, SE)
Abstract Slides Video
Presentation thumbnail
Outcomes of ST-Elevation Myocardial Infarction due to spontaneous coronary artery dissection: a nationwide cohort sample.
Doctor A. Elkaryoni (Providence, US)
Abstract Slides Video

Access the full session

Session thumbnail
Highlights from the Young in coronary artery disease

The Event

Event poster

ESC Congress 2021 - The Digital Experience

27 August - 30 August 2021

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources